Linda (Yueyue) Wang, PhD, MBA
PhD in Molecular Biology
Extensive experience in licensing and business development
Ex-Lilly and Sinopharm Investment
Dr. Linda Wang has a PhD in Molecular Biology and MBA. She has engaged in numerous licensing, technology transfer, co-development, JV, investment, M&A, and spin-off programs while working with Eli Lilly, Shyndec, and Sinopharm Investment, where she was managing partner of Industry Development.
She is based in Shanghai where her company T-Capital leads corporate finance activities for Chinese companies.